| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.026 | 0.6 |